The US has exempted India and 19 other nations from its new 100% Section 232 tariff on patented pharmaceuticals, covering specialty drugs for rare diseases, gene therapies and veterinary medicine. Generic drugs and their ingredients remain entirely outside the tariff's scope.
Read Full ArticlePiyush Goyal leads a 60-member delegation to Israel to accelerate India–Israel FTA talks, focusing on trade, defence, agriculture, technology and investment.
Granules Life Sciences secures its first U.S. FDA approval for the Hyderabad facility after a successful inspection, marking a major milestone in global expansion.
SC questions if Uniform Code for Pharma Marketing Practices 2024 is truly enforced or just a ‘toothless tiger’, seeks Centre’s response.
The Delhi High Court has ruled in favour of Pharmacyclics LLC and Johnson & Johnson Pvt Ltd (Johnson & Johnson) in a patent infringement suit moved by them for violation of their rights in targeted cancer treatment drug, Ibrutinib, marketed as Imbruvica. Find out all about the case here.
The Senior Citizen Rights Handbook is a comprehensive guide designed to empower elderly citizens with clear and accessible knowledge of their legal and social rights in India.
![Pharmacyclics, Johnson & Johnson win patent infringement suit for anti-cancer drug [Read Judgment]](/secure/uploads/2024/01/lj_5765_WhatsApp_Image_2024-01-03_at_5.45.56_PM.jpeg)
